Stay updated on ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a small update to the page.
    Difference
    0.0%
    Check dated 2026-07-03T23:15:49.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a newer page revision. This update does not modify the study details or other visible content.
    Difference
    0.0%
    Check dated 2026-06-26T23:15:44.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page adds a recruitment status note indicating no longer looking for participants and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study); it also reformats the 'Intervention / Treatment' label to 'Intervention/Treatment' and updates the revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:30:39.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates an updated version of the page’s documentation/assets.
    Difference
    0.0%
    Check dated 2026-06-05T11:42:10.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.3 to v3.5.4, indicating a new revision in the revision history. This update does not alter the content or behavior of the page.
    Difference
    0.0%
    Check dated 2026-05-14T23:01:25.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.2 to v3.5.3, reflecting a new template release. It does not change the displayed study details or layout for users.
    Difference
    0.0%
    Check dated 2026-04-30T14:11:45.000Z thumbnail image

Stay in the know with updates to ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARRY-382 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.